Tag Archives: Federal Circuit

Chemours Co. v. Daikin Industries – Back to Some IP Basics

After trying to untie the Gordian knot of patent eligibility, it is almost IP comfort food to read a Fed. Cir. decision that deals with obviousness. In Chemours Co. FC, LLC v Daikin Industries, Ltd., Appeal Nos. 2020-1289 and 2020-1290 … Continue reading

Posted in Obviousness | Tagged , | Leave a comment

Biogen v. Serano – When is a Recombinant Polypeptide Novel?

When I posted about this Fed. Cir. decision (Biogen MA v. EMD Serano, Appeal no. 2019-1133 (Fed. Cir., Sept. 28, 2020) on October 12, 2020, I viewed it as a straightforward application of the maxim that an otherwise non-novel product … Continue reading

Posted in Anticipation | Tagged , , , | Leave a comment

Biden’s Nominee to the Fed. Cir. is Perkins Coie Litigator

Tiffany P. Cunningham is a partner in the patent litigation practice of Perkins Coie. Importantly, she has a degree in Chemical Engineering from M.I.T. before receiving her J.D. from Harvard. The Court is in need of a judge that is … Continue reading

Posted in Federal Circuit News | Tagged , | Leave a comment

American Axle Petitions for Cert.

You may have noticed that I haven’t been posting since November. I feel like IP law has hunkered down and I find spats over jurisdiction and even the appeal urging the S. Ct. to validate IPR judgeships to be less … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , | Leave a comment